Accurate serology for SARS-CoV-2 and common human coronaviruses using a multiplex approach
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 9 (1) , 1965-1973
Abstract
Serology is a crucial part of the public health response to the ongoing SARS-CoV-2 pandemic, but there are still many unknowns. Here, we describe the development, validation and clinical evaluation of a protein micro-array as a quantitative multiplex immunoassay that can identify S and N-directed SARS-CoV-2 IgG antibodies with high specificity and sensitivity and distinguish them from all currently circulating human coronaviruses. The method specificity was 100% for SARS-CoV-2 S1 and 96 % for N antigen based on extensive syndromic (n=230 cases) and population panel (n=94) testing that also confirmed the high prevalence of seasonal human coronaviruses. To assess the potential role of the protein micro-array for both SARS-CoV-2 patient diagnostics and population studies, we evaluated a large heterogeneous COVID-19 cohort (n=330) and found an overall sensitivity of 89% (≥ 21 days post onset symptoms (dps)), which ranged from 86% to 96% depending on severity of disease. For a subset of these patients longitudinal samples were provided up to 56 dps. We observed an absent or delayed, and lower SARS-CoV-2 antibody responses in mild cases. Overall, we present the development and extensive clinical validation of a multiplex human coronavirus serological assay that can be used for syndromic testing, to answer research questions regarding human coronavirus antibody responses, to support SARS-CoV-2 diagnostics where RT-PCR lacks in sensitivity and to evaluate epidemiological developments efficiently and with high-throughput.Keywords
This publication has 32 references indexed in Scilit:
- SARS and MERS: recent insights into emerging coronavirusesNature Reviews Microbiology, 2016
- Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013–2014Emerging Infectious Diseases, 2015
- UpSet: Visualization of Intersecting SetsIEEE Transactions on Visualization and Computer Graphics, 2014
- Evolution of an influenza pandemic in 13 countries from 5 continents monitored by protein microarray from neonatal screening bloodspotsJournal of Clinical Virology, 2014
- Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological studyThe Lancet Infectious Diseases, 2013
- Specific serology for emerging human coronaviruses by protein microarrayEurosurveillance, 2013
- Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal VaccinationPLOS ONE, 2013
- Profiling of humoral immune responses to influenza viruses by using protein microarrayClinical Microbiology and Infection, 2012
- The dominance of human coronavirus OC43 and NL63 infections in infantsJournal of Clinical Virology, 2012
- Human Coronavirus NL63 and 229E Seroconversion in ChildrenJournal of Clinical Microbiology, 2008